Skip to main content

Table 1 Comparison of demographic, treatment, and cancer-related variables between AM- recommended treatment regimen patients and non-AM recommended treatment regimen patients

From: Barriers and challenges in integration of anthroposophic medicine in supportive breast cancer care

Characteristic

Total cohort N = 341, n (%)

AM group N = 56, n (%)

Non-AM group N = 285, n (%)

P value

Age [Mean in years ± SD (median)]

62.26 ± 12.58 (63)

64.05 ± 11.55 (64.5)

61.91 ± 12.77 (63)

0.24

Sex

  Male

84 (24.6)

12 (21.4)

72 (25.3)

0.63

  Female

257 (75.4)

44 (78.6)

213 (74.7)

Main language*:

  Hebrew

243 (73.4)

47 (85.5)

196 (71.0)

Hebrew vs. non-Hebrew

  Arabic

32 (9.7)

3 (5.5)

29 (10.50)

  Russian

56 (16.9)

5 (9.1)

 

P = 0.029

Country of birth*

  Israel

157 (48.2)

28 (52.8)

129 (47.3)

Israeli-born vs. others

  Europe/America

84 (25.8)

13 (24.5)

71 (26.0)

  Asia/Africa

30 (9.2)

6 (11.3)

24 (8.8)

P = 0.55

  Former USSR

55 (16.9)

6 (11.3)

49 (17.9)

Residence distance*

  Haifa**

134 (39.3)

21 (37.5)

113 (39.6)

0.88

  Suburbs**

130 (38.1)

21 (37.5)

109 (38.2)

  Periphery**

77 (22.6)

14 (25.0)

63 (22.1)

Cancer sites*

  Breast

138 (41.8)

24 (44.4%)

114 (41.3%)

0.76

  Gynecological

65 (19.7%)

13 (24.1%)

52 (18.8%)

0.36

  Gastrointestinal

78 (23.6%)

10 (18.5%)

68 (24.6%)

1.00

  Prostate + urologic

31 (9.4%)

5 (9.3%)

26 (9.4%)

0.38

  Lung

18 (5.5%)

2 (3.7%)

16 (5.8%)

0.74

Cancer recurrence*

  Recurrent

82 (24.0)

19 (33.9)

63 (22.1)

0.062

  Non-recurrent

259 (76.0)

37 (66.1)

222 (77.9)

Evidence for advanced cancer*

  Metastases

159 (46.6)

28 (50.0)

131 (46.0)

0.66

  Non-metastatic

182 (53.4)

28 (50.0)

154 (54.0)

Chemotherapy setting*

  Neoadjuvant + adjuvant

209 (65.7)

34 (61.8)

175 (66.5)

0.53

  Palliative + Curative

109 (34.3)

21 (38.2)

88 (33.5)

Non-cancer related CM use*

  Users

165 (48.5)

42 (75.0)

123 (43.3)

<0.0001

  Non-users

175 (51.5)

14 (25.0)

161 (56.7)

Cancer-related CM use*

  Users

170 (50.1)

39 (69.9)

131 (46.3)

0.002

  Non-users

169 (49.9)

17 (30.4)

152 (53.7)

  1. Notes:
  2. SD standard deviation; Data analysis was performed by t-test, Fisher’s exact test, and Pearson Chi-square test.
  3. * Data is limited to the number of respondents who reported this information.
  4. **In relation to residential distance from Haifa: suburbs – up to 20 km from Haifa; periphery –beyond 20 km from Haifa.